title: NDRG1 as a molecular target to inhibit the epithelial-mesenchymal transition: the case for developing inhibitors of metastasis.
authors.affiliation: Molecular Pharmacology & Pathology Program, Department of Pathology & Bosch Institute, Blackburn Building (D06), University of Sydney, Sydney, New South Wales, 2006 Australia.
authors.forename: Sumit
authors.initials: S
authors.lastname: Sahni
authors.forename: Sukriti
authors.initials: S
authors.lastname: Krishan
authors.forename: Des R
authors.initials: DR
authors.lastname: Richardson
mesh_terms: D000818:Animals; D018797:Cell Cycle Proteins / Q000187:drug effects* / Q000235:genetics; D058750:Epithelial-Mesenchymal Transition / Q000187:drug effects*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000187:drug effects* / Q000235:genetics; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D000099259:N-myc Downstream-Regulated Gene 1 Protein
chemical_list: D018797:Cell Cycle Proteins; D047908:Intracellular Signaling Peptides and Proteins; D000099259:N-myc Downstream-Regulated Gene 1 Protein
keywords: NDRG1; epithelial–mesenchymal transition; iron; metastasis; thiosemicarbazones